Columbia researchers have discovered a genetic variant that reduces the odds of developing Alzheimer’s disease by up to 70% and may be protecting thousands of people in the United States from the disease. The study, “Rare genetic variation in Fibronectin 1 (FN1) protects against APOEε4 in Alzheimer’s disease,” was published online in the journal Acta Neuropathologica.